China has recorded a major medical breakthrough with its domestically developed Ebola vaccine. The vaccine has been developed by the country's Academy of Military Medical Sciences. And has now been granted permission to be tested in overseas clinical trials. Preliminary results show that a single shot can produce antibodies against the Ebola virus 14 days after innoculation, reaching peak resistance at 28 days. The vaccine specifically targets the strain of the virus that hit West Africa in 2014. Ebola is a haemorragic virus which is deadly if not treated.